Immunome Inc. trailing returns
How Immunome Inc. (IMNM) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -5.3% | +0.0% | -5.3% | — |
| 5 days | -15.8% | +0.0% | -15.8% | -15.8%Oct 16 |
| 1 month | -29.8% | +0.0% | -29.8% | -36.0%Oct 16 |
| YTD | -23.3% | +0.0% | -23.3% | -44.8%Oct 16 |
| 1 year | -0.1% | +0.0% | -0.1% | -44.8%Oct 2026 |
| 5 years | -1.3% | +0.0% | -1.3%-6.5% | -90.6%Dec 2022 |
| Since inception (2020) | +3.4% | +0.0% | +3.4%+22.5% | -94.9%Dec 2022 |
Growth of IMNM#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years-1.3%/year · -6.5%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in IMNM's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Immunome Inc.'s return since inception?
- Since 2020, Immunome Inc. (IMNM) has compounded at about +3.4% a year — +22.5% in total.